These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 39022902)

  • 1. The roles of TRPC6 in renal tubular disorders: a narrative review.
    Sheng A; Liu F; Wang Q; Fu H; Mao J
    Ren Fail; 2024 Dec; 46(2):2376929. PubMed ID: 39022902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation.
    Hou X; Xiao H; Zhang Y; Zeng X; Huang M; Chen X; Birnbaumer L; Liao Y
    Cell Death Dis; 2018 Oct; 9(10):1015. PubMed ID: 30282964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
    Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
    Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPC Channels in the Physiology and Pathophysiology of the Renal Tubular System: What Do We Know?
    Englisch CN; Paulsen F; Tschernig T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPC6 Knockout Alleviates Renal Fibrosis through PI3K/AKT/GSK3B Pathway.
    Sun AB; Li FH; Zhu L; Zeng XX; Zhu M; Lei QH; Liao YH
    Curr Med Sci; 2024 Jun; 44(3):589-602. PubMed ID: 38748370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.
    Ma R; Chaudhari S; Li W
    Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of TRPC6 channels in the development of human renal cell carcinoma.
    Song J; Wang Y; Li X; Shen Y; Yin M; Guo Y; Diao L; Liu Y; Yue D
    Mol Biol Rep; 2013 Aug; 40(8):5115-22. PubMed ID: 23700295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPC6 May Protect Renal Ischemia-Reperfusion Injury Through Inhibiting Necroptosis of Renal Tubular Epithelial Cells.
    Shen B; He Y; Zhou S; Zhao H; Mei M; Wu X
    Med Sci Monit; 2016 Feb; 22():633-41. PubMed ID: 26913924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Tubular Epithelial TRPA1 Acts as An Oxidative Stress Sensor to Mediate Ischemia-Reperfusion-Induced Kidney Injury through MAPKs/NF-κB Signaling.
    Wu CK; Wu CL; Lee TS; Kou YR; Tarng DC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA26a inhibits cisplatin-induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin-related protein 1.
    Yang Y; Li ZL; Wang FM; Tang RN; Tu Y; Liu H
    Cell Biochem Funct; 2020 Jun; 38(4):384-391. PubMed ID: 31887787
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sun R; Han M; Liu Y; Su Y; Shi Q; Huang L; Kong L; Li W; Li W
    Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38038121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome.
    Zheng Z; Xu Y; Krügel U; Schaefer M; Grune T; Nürnberg B; Köhler MB; Gollasch M; Tsvetkov D; Markó L
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.
    't Hart DC; van der Vlag J; Nijenhuis T
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway.
    Kim JH; Hwang KH; Eom M; Kim M; Park EY; Jeong Y; Park KS; Cha SK
    FASEB J; 2019 Jul; 33(7):8588-8599. PubMed ID: 31022353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways.
    Gu LF; Ge HT; Zhao L; Wang YJ; Zhang F; Tang HT; Cao ZY; Yu BY; Chai CZ
    Front Pharmacol; 2020; 11():996. PubMed ID: 32719603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperlonguminine attenuates renal fibrosis by inhibiting TRPC6.
    Zhou L; Wu K; Gao Y; Qiao R; Tang N; Dong D; Li XQ; Nong Q; Luo DQ; Xiao Q; Fan X; Duan Q; Cao W
    J Ethnopharmacol; 2023 Sep; 313():116561. PubMed ID: 37121453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient Receptor Potential Canonical 6 (TRPC6) Channel in the Pathogenesis of Diseases: A Jack of Many Trades.
    Saqib U; Munjuluri S; Sarkar S; Biswas S; Mukherjee O; Satsangi H; Baig MS; Obukhov AG; Hajela K
    Inflammation; 2023 Aug; 46(4):1144-1160. PubMed ID: 37072606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPC6 inhibits renal tubular epithelial cell pyroptosis through regulating zinc influx and alleviates renal ischemia-reperfusion injury.
    Shen B; Mei M; Ai S; Liao X; Li N; Xiang S; Wen C; Tao Y; Dai H
    FASEB J; 2022 Oct; 36(10):e22527. PubMed ID: 36036542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.